期刊文献+

首发未用药精神分裂症患者的认知功能与感觉门控P50的关系 被引量:4

Correlation between cognitive function and P50 sensory gating in patients with drug-nave first-episode schizophrenia
下载PDF
导出
摘要 目的:探讨首发精神分裂症患者的认知功能与感觉门控P50关系。方法:使用美国精神障碍诊断与统计手册第4版(DSM-Ⅳ)轴Ⅰ临床定式检查诊断首发精神分裂症住院患者106例,86名来自社区并且年龄、性别、受教育程度与患者匹配正常对照,采用听觉条件(S1)-测试(S2)刺激范式对所有研究对象进行P50检测,检测指标为S1、S2潜伏期和波幅,S2/S1抑制率,(Sl-S2)差值。根据抑制比,将S2/S1≤0.4定义为抑制比正常,S2/S1>0.4定义为抑制比异常。采用精神分裂症认知功能成套测验中文版(MCCB)评估所有对象认知功能。结果:精神分裂症患者的S1潜伏期、S2潜伏期长于正常对照组,S1波幅、(S1-S2)波幅低于对照组,S2/S1抑制率显著高于对照组(均P<0.01);精神分裂症患者的M CCB各维度得分均低于对照组(均P<0.05)。精神分裂症患者P50抑制率正常、异常者的M CCB分测验评分及总分差异无统计学意义(均P>0.05)。多元逐步回归分析显示P50抑制率、(S1-S2)波幅与M CCB评分的相关性无统计学意义(均P>0.05)。结论:首发精神分裂症患者的认知功能可能与感觉门控P50抑制缺陷无关联。 Objective:To explore the relation of cognitive function correlates to P50 sensory gating in patients with schizophrenia.Methods:Totally 106 patients with drug-naiive first-episode schizophrenia and 86 healthy con-trol subjects matched for age,sex and education were recruited.All patients met the Diagnostic and Statistical Man-ual of Mental Disorders,Fourth Edition (DSM-IV)criteria for schizophrenia.Their cognitive function were assessed with the MATRICS Consensus Cognitive Battery (MCCB).The P50 auditory gating potential were recorded in all subjects using conditioning-testing stimulus paradigm and stimulus train paradigm.The P50 components were meas-ured in S1 S2 latency,S1 S2 amplitude and P50 suppression ratios.Results:Compared with the controls subjects, the patients with schizophrenia had significantly longer S1[60.8 ±7.8)ms vs.(56.3 ±7.0)ms,P〈0.05]S2 la-tency [(59.1 ±10.2)ms vs.(55.7 ±10.7)ms,P 〈0.05],lower S1 amplitude [(2.8 ±1.8)μV vs.(3.5 ±1.6)μV,P 〈0.05],less amplitude difference (S1-S2)[(1.5 ±1.8)μV vs.(2.2 ±1.4)μV,P 〈0.05]and higher P50 suppression ratios (S2 /S1 )[(59.7 ±65.6)vs.(37.6 ±30.0),P 〈0.05].Schizophrenia patients had lower score than control subjects in all cognitive domains of MCCB (Ps 〈0.05).No differences in neurocognitive performance were found between subjects in the normal P50 ratio and the abnormal in healthy controls or patients with schizo-phrenia (Ps 〉0.05).No significant correlation was found between P50 gating measures (P50 ratio and P50 ampli-tude difference)and neuropsychological measures in MCCB scores (Ps &gt;0.05).Conclusion:There may be no as-sociation between P50 deficits and cognitive measures in patients with drug-na&#168;ive first-episode schizophrenia.
机构地区 北京回龙观医院
出处 《中国心理卫生杂志》 CSSCI CSCD 北大核心 2015年第10期733-737,共5页 Chinese Mental Health Journal
基金 美国国立精神卫生研究所(NIMH)资助项目(H-22473) 北京回龙观医院重点学科扶持基金(2014LYZD-02)
关键词 首发精神分裂症 听觉感觉门控 P50 认知功能 first-episode schizophrenia auditory gating P50 cognitive function
  • 相关文献

参考文献19

二级参考文献41

  • 1朱春燕,汪凯,Lee TMC.执行功能与精神分裂症[J].心理科学进展,2004,12(5):743-751. 被引量:25
  • 2安宝富,王长虹,李晏.利培酮对精神分裂症认知功能和血清细胞因子水平的影响[J].中国神经精神疾病杂志,2006,32(3):249-252. 被引量:10
  • 3王红星,张明岛,陈兴时,楼翡璎,梁建华,陈冲,史天涛,吕秋霖.精神分裂症首次发病患者和健康成年人听觉感觉门控电位P50的研究[J].中华精神科杂志,2006,39(2):65-68. 被引量:24
  • 4陈兴时,张明岛,楼翡璎,王红星,王继军,郭旗,刘丽,高存友,刘萍,刘效巍,段慧君,郭凤莲,梁建华,陈冲,陈欣伟.精神分裂症首次发病患者治疗前后感觉门控功能的动态观察[J].中华精神科杂志,2006,39(4):193-196. 被引量:21
  • 5Yamashita C, Mizuno M, Nemoto T, et al. Social cognitive problem-solving in schizophrenia: associations with fluency and verbal memory. Psychiatry Res, 2005, 134 : 123-129.
  • 6Penades R, Boget T, Catalon R, et al. Cognitive mechanisms, psychosocial functioning, and neurocognitive rehabilitation in schizophrenia. Schizophr Res, 2003,63:219-227.
  • 7Marder SR, Fenton W. Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia. Schizophr Res, 2004, 72:5-9.
  • 8Kern RS, Green MF, Nuechterlein KH, et al. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr Res, 2004,72:11-19.
  • 9Green MF, Nueehterlein KH. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr Res, 2004, 72 : 1-3.
  • 10Green MF, Nuechterlein KH, Gold JM, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry, 2004,56:301-307.

共引文献552

同被引文献50

  • 1Hu L, Boutros NN, Jansen BH. Sensory gating-out and gating-ill in normal and schizophrenic participants [J]. Clin EEG Neurosci,2012, 43 C 1 ) : 23-31.
  • 2S a nchez -Morla EM , S*antos JL , Aparicio A , et al.Neuropsychological corre-lates of P50 sensory gating in patients withschizophrenia[J]. Schizophrenia Res, 2013, 143 ( 1 ) : 102-106.
  • 3Sanchez-Morla, EM, SantosJL, Aparicio A, et al. Antipsychoticeffects on auditory sensory gating in schizophrenia patients[J]. EurNeuropsychopharmacol, 2009,19 ( 12 ) : 905-909.
  • 4Hong X,Chan RC, Zhuang X, et al. Neuroleptic effects onP50 sensory gating in patients with first-episode never-medicatedschizophrenia[j]. Schizophr Res, 2009,108 ( 1-3) : 151 - 157.
  • 5Nagamoto HT, Adler LE, McRea KA, et al. Auditory P50in schizophrenics on clozapine : improved gating parallelsclinical improvement and changes in plasma 3 -methoxy -4 -hydroxyphenylgly col [J]. Neuropsychobiology, 1999,39 ( 1 ) : 10-17.
  • 6Oranje B, Aggernaes B, Rasmussen H,et al. P50 suppressionand its neural generators in antipsychotic -na l ve first-episodeschizophrenia before and after 6 months of quetiapine treatmenc[J].Schizophr Bull, 2013, 39 ( 2 ) : 472-480.
  • 7Turetsky BI,Dent G, Jaeger J, et al. P50 amplitude reduction :a nicotinic receptor-mediated deficit in first-degree relatives ofschizophrenia patients[J]. Psychopharmacology, 2012,221 ( 1 ):39-52.
  • 8Cardenhead KS, Light GA, Shafer KM, et al.P50 suppression inindividuals at risk for schizophrenia : the convergence of clinical,familial, and vulnerability marker risk assessmentQJ. Biol Psychiatry,2005, 57 ( 12) : 1504-1509.
  • 9Waldo MC, Adler LE, Leonard S, et al. Familial trans mission ofrisk factors in the first degree relatives of schizophrenic people[J].BiolPsychiatry, 2000,47 (3 ): 231-239.
  • 10Li CT, Chen LF, Tu PC, et al. Impaired prefronto-thalamicfunctional con一nectivity as a key feature of treatment-resistantdepression : a combined MEG, PET and rTMS study[)]. PLoS One,2013,8(8): e70089.

引证文献4

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部